Pfizer’s FDA approval is boosting these stocks
By Julia Horowitz, CNN Business Since 2020, investors have been rallying behind shares of Pfizer and Germany’s BioNTech, two companies that were poised to play a crucial role in helping bring an end to a devastating pandemic. Those bets have paid off. What’s happening: On Monday, the US Food and Drug Administration granted full approval
Continue Reading